Pyrimido(5,4-e)(1,2,4)triazine-5,7-diones, methods for producing the same and their use

Details for Australian Patent Application No. 2004205351 (hide)

Owner Aventis Pharma Deutschland GmbH

Inventors Petry, Stefan; Baringhaus, Karl-Heinz; Tennagels, Norbert; Mueller, Guenter

Agent Watermark

Pub. Number AU-A-2004205351

PCT Pub. Number WO2004/065387

Priority 103 01 788.7 20.01.03 DE

Filing date 7 January 2004

Wipo publication date 5 August 2004

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 031/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

4 August 2005 PCT application entered the National Phase

  PCT publication WO2004/065387 Priority application(s): WO2004/065387

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004205352-Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof

2004205350-2.4-dihalogen-6-(C2-C3-alkyl)-phenyl substituted tetramic acid derivatives